CAPRICOR THERAPEUTICS, INC. (CAPR) Debt Components
- 2021-12-31: Notes Payable, CurrentUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Decrease, ForgivenessUSD (m); Debt Instrument, Unamortized Discount (Premium), NetUSD (m).
- 2021-09-30: Notes Payable, CurrentUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Decrease, ForgivenessUSD (m); Debt Instrument, Unamortized Discount (Premium), NetUSD (m).
- 2021-06-30: Notes Payable, CurrentUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Decrease, ForgivenessUSD (m); Debt Instrument, Unamortized Discount (Premium), NetUSD (m).
- 2021-03-31: Notes Payable, CurrentUSD $282.69K; Long-term Line of CreditUSD (m); Debt Instrument, Decrease, ForgivenessUSD (m); Debt Instrument, Unamortized Discount (Premium), NetUSD (m).
CAPRICOR THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Line of Credit USD | Debt Instrument, Decrease, Forgiveness USD | Debt Instrument, Unamortized Discount (Premium), Net USD |
|---|---|---|---|---|
| 2021-12-31 | $0.00 | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | (m) | (m) | (m) |
| 2021-03-31 | $282.69K | (m) | (m) | (m) |
| 2020-12-31 | $246.69K | (m) | (m) | (m) |
| 2020-09-30 | $193.24K | (m) | (m) | (m) |
| 2020-06-30 | $139.93K | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | 1 month · $15.70M | (m) |
| 2014-12-31 | (m) | $9.16M | (m) | (m) |
| 2013-09-30 | $326.80K | (m) | (m) | $123.20K |
| 2013-06-30 | $258.51K | (m) | (m) | $191.49K |
| 2013-03-31 | $190.97K | (m) | (m) | $259.03K |
| 2012-12-31 | $0.00 | (m) | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |